Phase II study of docetaxel and gemcitabine combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy.
about
Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials.Gemcitabine-induced severe pulmonary toxicity.Docetaxel in advanced non-small cell lung cancer.Nanotechnology applications in thoracic surgery.Docetaxel in the treatment of advanced non-small-cell lung cancer.
P2860
Phase II study of docetaxel and gemcitabine combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Phase II study of docetaxel an ...... failing previous chemotherapy.
@ast
Phase II study of docetaxel an ...... failing previous chemotherapy.
@en
type
label
Phase II study of docetaxel an ...... failing previous chemotherapy.
@ast
Phase II study of docetaxel an ...... failing previous chemotherapy.
@en
prefLabel
Phase II study of docetaxel an ...... failing previous chemotherapy.
@ast
Phase II study of docetaxel an ...... failing previous chemotherapy.
@en
P2093
P1476
Phase II study of docetaxel an ...... failing previous chemotherapy.
@en
P2093
Chun-Ming Tsai
Hsiao-Wei Wu
Jacqueline Whang-Peng
Reury-Perng Perng
Wei-Chun Lin
Yuh-Min Chen
P304
P356
10.1097/00000421-200210000-00017
P577
2002-10-01T00:00:00Z